Furthermore, patients with DLE (a subtype of cutaneous lupus erythematosus) whose main manifestation was skin lesions, displayed much more increased AIM2 levels than patients with SLE, suggesting the clinical implication of AIM2, particularly in skin lesion features of lupus patients. This evidence concerns the gene AIM2 and discoid lupus erythematosus.